Skip to main content
. 2020 Apr 10;12(1):1748322. doi: 10.1080/19420862.2020.1748322

Figure 3.

Figure 3.

Biodistribution results. Tissue uptake (%ID/g) with the administration of 0.5 mg/kg 89Zr-labeled IBI322 at 72 h and 168 h in transgenic mice (B-hCD47; genotype: h/h) bearing an MC38 tumor (hCD47 and hPDL1) (a). CD47 and PD-L1 IHC staining and H&E staining of the tumors (Scale bar: 200 µm) (b). Black arrow indicates positive expression.